Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial()(): A TITE-CRM Phase I/II Clinical Trial

BACKGROUND: Kim et al. report two patients with melanoma metastases to the brain that responded to treatment with RRx-001 and whole brain radiotherapy (WBRT) without neurologic or systemic toxicity in the context of a phase I/II clinical trial. RRx-001 is an reactive oxygen and reactive nitrogen spe...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Transl Oncol
Hoofdauteurs: Kim, Michelle M., Parmar, Hemant, Cao, Yue, Pramanik, Priyanka, Schipper, Matthew, Hayman, James, Junck, Larry, Mammoser, Aaron, Heth, Jason, Carter, Corey A., Oronsky, Arnold, Knox, Susan J., Caroen, Scott, Oronsky, Bryan, Scicinski, Jan, Lawrence, Theodore S., Lao, Christopher D.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Neoplasia Press 2016
Onderwerpen:
Original article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4833892/
https://ncbi.nlm.nih.gov/pubmed/27084426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2015.12.003
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items